Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-
A1932 (-)-Huperzine ATarget: NMDA Receptors|AChESummary: NMDA receptor antagonist/AChE inhibitor
-
A8190 Semagacestat (LY450139)Summary: γ-secretase inhibitor
-
A8200 DAPT (GSI-IX)6 CitationSummary: γ-secretase inhibitor,potent and specific
-
A1038 Amyloid β-Peptide (10-20) (human)Summary: Initiates neurodegeneration in Alzheimer disease
-
A1039 Amyloid Beta-peptide (25-35) (human)1 CitationSummary: Functional domain of Aβ
-
A1040 Myelin Basic Protein (87-99)Summary: Encephalitogenic peptide
-
A1123 Amyloid Beta-Peptide (12-28) (human)Summary: sequence H2N-VHHQKLVFFAEDVGSNK-OH
-
A1124 Amyloid Beta-Peptide (1-40) (human)1 CitationSummary: Amyloid precursor protein
-
A1131 COG 133Summary: ApoE mimetic peptide
-
A1002 Beta-Amyloid (1-11)Summary: Amyloidogenic peptide